幼儿致命性呼吸道合胞病毒病。
Fatal enhanced respiratory syncytial virus disease in toddlers.
机构信息
Fundación INFANT, Buenos Aires, Argentina.
Vanderbilt University, Nashville, TN, USA.
出版信息
Sci Transl Med. 2021 Oct 20;13(616):eabj7843. doi: 10.1126/scitranslmed.abj7843.
Abstract
In 1967, two toddlers immunized with a formalin-inactivated vaccine against respiratory syncytial virus (FIRSV) in the United States died from enhanced RSV disease (ERD), a severe form of illness resulting from aberrant priming of the antiviral immune response during vaccination. Up to 80% of immunized children subsequently exposed to wild-type virus were hospitalized. These events hampered RSV vaccine development for decades. Here, we provide a characterization of the clinical, immunopathological, and transcriptional signature of fatal human ERD, outlining evidence for safety evaluation of RSV vaccines and a framework for understanding disease enhancement for pathogens in general.
摘要
1967 年，美国的两名幼儿在接种了针对呼吸道合胞病毒（RSV）的福尔马林灭活疫苗（FIRSV）后死于增强型 RSV 疾病（ERD），这是一种由疫苗接种期间抗病毒免疫反应异常引发的严重疾病。多达 80%的接种儿童随后因暴露于野生型病毒而住院。这些事件阻碍了 RSV 疫苗的开发数十年。在这里，我们对致命性人类 ERD 的临床、免疫病理学和转录特征进行了描述，为 RSV 疫苗的安全性评估提供了证据，并为一般病原体疾病增强的理解提供了框架。
相似文献
1
Fatal enhanced respiratory syncytial virus disease in toddlers.幼儿致命性呼吸道合胞病毒病。
Sci Transl Med. 2021 Oct 20;13(616):eabj7843. doi: 10.1126/scitranslmed.abj7843.
2
Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.呼吸道合胞病毒增强疾病的简史与特征
Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95. doi: 10.1128/CVI.00609-15.
3
Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.病毒样颗粒疫苗引发免疫反应，预防针对呼吸道合胞病毒的灭活病毒疫苗增强型疾病。
Virology. 2017 Nov;511:142-151. doi: 10.1016/j.virol.2017.08.022. Epub 2017 Aug 29.
4
Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.在棉鼠模型中，低剂量重组融合后或融合前呼吸道合胞病毒F免疫接种引发疫苗增强疾病，与Th1偏向佐剂（GLA-SE）或Th2偏向佐剂（明矾）的存在无关。
J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.02180-16. Print 2017 Apr 15.
5
Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.疫苗和相关生物制品咨询委员会会议摘要，会议旨在评估预防 RSV -naive 婴儿呼吸道合胞病毒病的候选疫苗。
Vaccine. 2020 Jan 10;38(2):101-106. doi: 10.1016/j.vaccine.2019.10.048. Epub 2019 Nov 6.
6
Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine.揭示导致与灭活呼吸道合胞病毒疫苗相关的增强呼吸道疾病的综合功能途径。
Front Immunol. 2019 Mar 29;10:597. doi: 10.3389/fimmu.2019.00597. eCollection 2019.
7
A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats.一种含有单磷酰脂质 A 的病毒体呼吸道合胞病毒疫苗，在不给棉鼠增强疾病的情况下提供针对病毒挑战的保护。
Influenza Other Respir Viruses. 2013 Nov;7(6):1227-36. doi: 10.1111/irv.12112. Epub 2013 Apr 10.
8
Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple.非典型麻疹与强化呼吸道合胞病毒病（ERD）简说
Pediatr Res. 2007 Jul;62(1):111-5. doi: 10.1203/PDR.0b013e3180686ce0.
9
Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein.γ射线灭活呼吸道合胞病毒疫苗可提供保护，但通过从融合前状态切换到融合后状态会加重肺部炎症。
Microbiol Spectr. 2023 Aug 17;11(4):e0135823. doi: 10.1128/spectrum.01358-23. Epub 2023 Jun 5.
10
Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.母体抗体增强呼吸道合胞病毒感染并不能解释婴儿疾病的严重程度。
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00851-17. Print 2017 Nov 1.
引用本文的文献
1
Post-marketing safety monitoring of RSV vaccines: A real-world study based on the Vaccine Adverse Event Reporting System (VAERS).呼吸道合胞病毒疫苗的上市后安全性监测：一项基于疫苗不良事件报告系统（VAERS）的真实世界研究。
Hum Vaccin Immunother. 2025 Dec;21(1):2550857. doi: 10.1080/21645515.2025.2550857. Epub 2025 Aug 27.
2
Respiratory syncytial virus: health burden, disease prevention, and treatment-recent progress and lessons learned.呼吸道合胞病毒：健康负担、疾病预防与治疗——近期进展与经验教训
Microlife. 2025 Feb 10;6:uqaf003. doi: 10.1093/femsml/uqaf003. eCollection 2025.
3
Cost-effectiveness analysis of nirsevimab for prevention of respiratory syncytial virus disease among infants in Shanghai, China: A modeling study.中国上海使用尼塞韦单抗预防婴儿呼吸道合胞病毒疾病的成本效益分析：一项建模研究。
Hum Vaccin Immunother. 2025 Dec;21(1):2506288. doi: 10.1080/21645515.2025.2506288. Epub 2025 May 20.
4
Preventing RSV Infection in Children: Current Passive Immunizations and Vaccine Development.预防儿童呼吸道合胞病毒感染：当前的被动免疫疗法与疫苗研发
Pathogens. 2025 Jan 21;14(2):104. doi: 10.3390/pathogens14020104.
5
The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease.呼吸道合胞病毒（RSV）感染动物模型的建立与增强型 RSV 疾病。
Viruses. 2024 Oct 30;16(11):1701. doi: 10.3390/v16111701.
6
Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue.抗呼吸道合胞病毒的疫苗和治疗药物：已解决和未解决的问题
MedComm (2020). 2024 Nov 21;5(12):e70016. doi: 10.1002/mco2.70016. eCollection 2024 Dec.
7
Vaccine skepticism and vaccine development stages; inoculation from "cowpox" lesion to the current mRNA vaccine of COVID-19: review.疫苗怀疑论与疫苗研发阶段；从“牛痘”损伤接种到当前的新冠mRNA疫苗：综述
Ther Adv Vaccines Immunother. 2024 Oct 11;12:25151355241288135. doi: 10.1177/25151355241288135. eCollection 2024.
8
Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction.重组呼吸道合胞病毒G蛋白疫苗通过白细胞介素-13和粘蛋白过度产生引发加重的呼吸道疾病。
NPJ Vaccines. 2024 Oct 12;9(1):187. doi: 10.1038/s41541-024-00987-w.
9
Analysis of Beyfortus (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention.Beyfortus（尼塞韦单抗）免疫接种活动分析：呼吸道合胞病毒预防中的有效性、偏倚和不良事件风险
Curr Issues Mol Biol. 2024 Sep 18;46(9):10369-10395. doi: 10.3390/cimb46090617.
10
Immune Responses and Protection Profiles in Mice Induced by Subunit Vaccine Candidates Based on the Extracellular Domain Antigen of Respiratory Syncytial Virus G Protein Combined with Different Adjuvants.基于呼吸道合胞病毒G蛋白胞外域抗原并结合不同佐剂的亚单位候选疫苗在小鼠体内诱导的免疫反应和保护情况
Vaccines (Basel). 2024 Jun 19;12(6):686. doi: 10.3390/vaccines12060686.
本文引用的文献
1
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.妊娠期接种呼吸道合胞病毒疫苗及其对婴儿的影响。
N Engl J Med. 2020 Jul 30;383(5):426-439. doi: 10.1056/NEJMoa1908380.
2
A proof of concept for structure-based vaccine design targeting RSV in humans.针对人类 RSV 的基于结构的疫苗设计的概念验证。
Science. 2019 Aug 2;365(6452):505-509. doi: 10.1126/science.aav9033.
3
Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases.对十年前的乳腺癌和相应脱钙骨转移进行外显子组捕获 RNA 测序。
JCI Insight. 2017 Sep 7;2(17). doi: 10.1172/jci.insight.95703.
4
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.全球、区域和国家 2015 年因呼吸道合胞病毒导致的幼儿急性下呼吸道感染疾病负担估计：系统评价和建模研究。
Lancet. 2017 Sep 2;390(10098):946-958. doi: 10.1016/S0140-6736(17)30938-8. Epub 2017 Jul 7.
5
Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors.呼吸道合胞病毒导致的死亡率。负担和危险因素。
Am J Respir Crit Care Med. 2017 Jan 1;195(1):96-103. doi: 10.1164/rccm.201603-0658OC.
6
RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets.呼吸道合胞病毒疫苗增强疾病是由不同CD4 T细胞亚群的联合作用所引发的。
PLoS Pathog. 2015 Mar 13;11(3):e1004757. doi: 10.1371/journal.ppat.1004757. eCollection 2015 Mar.
7
TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization.Toll样受体4（TLR4）基因型和环境脂多糖通过Th2极化介导呼吸道合胞病毒细支气管炎。
J Clin Invest. 2015 Feb;125(2):571-82. doi: 10.1172/JCI75183. Epub 2015 Jan 2.
8
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention.针对呼吸道合胞病毒融合蛋白前活跃形式的中和抗体为临床干预提供了独特的可能性。
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3089-94. doi: 10.1073/pnas.1115941109. Epub 2012 Feb 8.
9
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.edgeR：一个用于数字基因表达数据差异表达分析的 Bioconductor 包。
Bioinformatics. 2010 Jan 1;26(1):139-40. doi: 10.1093/bioinformatics/btp616. Epub 2009 Nov 11.
10
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease.由于Toll样受体刺激不足导致的抗体亲和力成熟缺陷会加重呼吸道合胞病毒疾病。
Nat Med. 2009 Jan;15(1):34-41. doi: 10.1038/nm.1894. Epub 2008 Dec 14.
Zotero 插件